This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Rubén Pio: Innovator in Adrenomedullin Research
Introduction
Rubén Pio is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of biomedical research, particularly in the study of adrenomedullin (AM) and its associated proteins. His work has implications for diagnosing and treating various diseases linked to abnormal AM levels.
Latest Patents
Rubén Pio holds a patent titled "Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith." This invention provides methods for the isolation, identification, and purification of AM-binding proteins. It also outlines techniques for utilizing these purified proteins to diagnose, treat, and monitor AM-related diseases, such as cancer and diabetes. The patent includes the identification of a complex between AM and a specific AM-binding protein, factor H (fH), and methods for treating conditions using antibodies that react with these complexes.
Career Highlights
Rubén Pio is affiliated with the National Institutes of Health, a component of the U.S. Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to groundbreaking research in the field of adrenomedullin and its implications for human health.
Collaborations
Rubén has collaborated with esteemed colleagues such as Frank Cuttitta and Ted H Elsasser. These partnerships have furthered the research and development of innovative methods for addressing AM-related diseases.
Conclusion
Rubén Pio's contributions to the field of biomedical research, particularly through his patent on AM-binding proteins, highlight his role as an innovator in the medical community. His work continues to pave the way for advancements in the diagnosis and treatment of serious health conditions.